This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


peer-reviewed publication

trusted source


SARS-CoV-2: How the history of human populations influences their immune response

SARS-CoV-2: How the history of human populations influences their immune response
Population single-cell responses to SARS-CoV-2 and IAV. a, The study design. The diagram was created using BioRender. b,c, Uniform manifold approximation and projection (UMAP) embedding of 1,047,824 PBMCs: resting (non-stimulated; NS) or stimulated with SARS-CoV-2 (COV) or IAV for 6 h. b, The colors indicate the 22 cell types inferred. c, The distribution of cells in the NS, COV and IAV conditions on UMAP coordinates. The contour plot indicates the overall density of cells, and the colored areas delineate regions of high cell density in each condition (NS (gray), COV (red) and IAV (blue)). Credit: Nature (2023). DOI: 10.1038/s41586-023-06422-9

During the COVID-19 pandemic, the clinical spectrum observed among people infected with SARS-CoV-2 ranged from asymptomatic carriage to death. Researchers at the Institut Pasteur, the CNRS and the Collège de France, in collaboration with researchers around the world, have investigated the extent and drivers of differences in immune responses to SARS-CoV-2 across populations from Central Africa, Western Europe and East Asia.

They show that latent cytomegalovirus infection and human genetic factors, driven by natural selection, contribute to population differences in to SARS-CoV-2 and the severity of COVID-19. Understanding the factors underlying such population disparities could help to improve patient management in future epidemics.

These results were published on August 9, 2023 in Nature.

The Institut Pasteur's Human Evolutionary Genetics Unit, led by Lluis Quintana-Murci, investigates how differ in their immune responses to infection. These differences may result from different environmental exposures or from past population history, including natural selection, shaping the patterns of genetic diversity of human groups.

In this study, the scientists investigated the extent and causes of disparities in the responses to the SARS-CoV-2 virus, focusing on populations from different geographic and ethnic backgrounds.

During the COVID-19 pandemic, the SARS-CoV-2 virus caused a wide range of clinical manifestation, from asymptomatic infection to fatal disease. Although advanced age remains a primary risk factor, male gender, comorbidities and various human genetic and immunological factors also contribute to disease severity. To study variations in immune responses to SARS-CoV-2 across human populations, scientists exposed immune blood cells from 222 healthy donors from Central Africa, Western Europe, and East Asia to the virus.

Single-cell RNA sequencing was used to analyze the SARS-CoV-2 responses of 22 blood cell types. These data were then combined with serological and collected from the same individuals, making it possible to assess the degree of disparity between populations in terms of their immune responses to SARS-CoV-2, and to identify contributing factors.

Scientists have identified around 900 genes that that respond differently to SARS-CoV-2 between populations. Using statistical genetic analyses, they show that these disparities are mainly due to variation in blood cellular composition: the proportion of each cell type differs from one population to another.

We know that blood cell composition can be influenced by environmental factors such as exposure to cytomegalovirus (a human infection of the herpes family, which is usually harmless) and cytomegalovirus prevalence varies widely among populations: Central Africans present 99% seropositivity, in contrast to only 50% in East Asians and 32% in Europeans. The team found that an individual's environment, specifically latent cytomegalovirus infection, will thus influence the immune cell response to SARS-CoV-2.

Furthermore, the scientists have identified around 1,200 whose expression in response to SARS-CoV-2 is under the control of human genetic factors and the frequency of the alleles that regulate these genes can vary between the populations studied. Using population genetics approaches, they have identified recurrent selection events targeting genes involved in anti-viral functions.

"We know that have had a strong impact on human survival and exerted massive selective pressures that have shaped population genetic variation. We show that past natural selection has impacted present immune responses to SARS-CoV-2, particularly in people of East Asian ancestry, in whom coronaviruses generated strong selective pressures around 25,000 years ago," explains Maxime Rotival, a researcher in the Institut Pasteur's Human Evolutionary Genetics Unit and co-last author of the study.

Between 1.5% and 2% of the genomes of Europeans and Asians is of Neanderthal origin. There is growing evidence of links between Neanderthal ancestry and present-day immunity to infection. By comparing the 1,200 genes identified with the Neanderthal genome, the scientists have discovered dozens of genes that both alter antiviral mechanisms and result from ancient introgression between Neanderthals and modern humans (Homo sapiens).

"Previous studies have shown the link between some of the genes identified in our study and the severity of COVID-19. Our comprehensive population-based study highlights the direct impact of genetic variants governing immune responses to SARS-CoV-2 on the severity of COVID-19. It also establishes links between past evolutionary events, such as or Neanderthal admixture, and current population disparities in immune responses and disease risk," explains Quintana-Murci, who is also Professor at the Collège de France and co-last author of the study.

"By identifying the precise cellular and molecular pathways of the genetic variants associated with COVID-19 severity, this study paves the way for precision medicine strategies that could either identify high-risk individuals or facilitate the development of new treatments," adds Darragh Duffy, Head of the Institut Pasteur's Translational Immunology Unit.

More information: Yann Aquino et al, Dissecting human population variation in single-cell responses to SARS-CoV-2, Nature (2023). DOI: 10.1038/s41586-023-06422-9

Journal information: Nature

Provided by Pasteur Institute

Citation: SARS-CoV-2: How the history of human populations influences their immune response (2023, August 26) retrieved 11 December 2023 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Neanderthals, environment, and evolution behind SARS-CoV-2 immune responses


Feedback to editors